57 stories tagged with #clinical-trial, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.
⌘ RSS feed for this tag → or search "Clinical Trial"
Cardiff Oncology, Inc. (CRDF) Discusses Updated Phase II CRDF-004 Data on Onvansertib in First-Line RAS-Mutated Metastatic Colorectal Cancer Transcript
Cardiff Oncology, Inc. (CRDF) Discusses Updated Phase II CRDF-004 Data on Onvansertib in First-Line RAS-Mutated Metastatic Colorectal Cancer June 3, 2026...…
Karyopharm Therapeutics Inc. (KPTI) Discusses Phase III SENTRY Trial Results of Selinexor Plus Ruxolitinib in Myelofibrosis Transcript
Karyopharm Therapeutics Inc. (KPTI) Discusses Phase III SENTRY Trial Results of Selinexor Plus Ruxolitinib in Myelofibrosis June 2, 2026 2:00 PM EDTCompany...…
Tenaya Therapeutics, Inc. (TNYA) Discusses Interim Data from MyPEAK-1 Trial of TN-201 Gene Therapy for MYBPC3-Associated HCM Transcript
Tenaya Therapeutics, Inc. (TNYA) Discusses Interim Data from MyPEAK-1 Trial of TN-201 Gene Therapy for MYBPC3-Associated HCM June 3, 2026 8:00 AM EDTCompany...…
Chiauranib Slows Platinum-Resistant Ovarian Cancer
The investigational drug extends progression-free survival in a phase 3 trial in patients with platinum-resistant or -refractory ovarian cancer.…
Phase 3: Rapid Relief in Thyroid Eye Disease With Veligrotug
A five-infusion course of veligrotug is well tolerated and results in rapid improvements in diplopia, proptosis, and disease activity in patients with thyroid eye disease, a phase …
Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function
A double-blind, placebo-controlled trial was conducted to study the effects of over-the-counter analgesic/antipyretic medications on virus shedding, immune response, and clinical s…
BioVie Inc. (BIVI) Discusses Clinical Updates on Bezisterim and BIV201 for Parkinson's, Alzheimer's, and Ascites Transcript
BioVie Inc. (BIVI) Discusses Clinical Updates on Bezisterim and BIV201 for Parkinson's, Alzheimer's, and Ascites June 2, 2026 4:15 PM EDTCompany...…
A cancer vaccine made just for you. mRNA is back and it's fighting melanoma
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.…
Cancer jab can eradicate entire tumours in patients, trial shows
Jab brought ‘unprecedentedly strong responses’ in patients whose disease had become resistant to chemotherapy and immunotherapy…
Trial of multi-cancer blood test among 142,000 NHS patients fails to meet main aim
Results presented at oncology conference in Chicago show Galleri test failed to reduce late-stage cancer diagnoses…
‘Holy grail’ sleep apnea pill can cut episodes by more than 50%
It could prove to be a saving grace for the roughly 80 million Americans who suffer from sleep apnea.…
Gene Editing May Help Treat Dangerously High Cholesterol with Just One Infusion
Learn how gene editing may help people born with dangerously high cholesterol lower their levels with just one infusion.…
Drug that grew extra teeth in mice enters first human trial
Researchers at Kyoto University Hospital have begun the first human trial of TRG-035, a drug meant to grow new teeth in people who are missing them. Humans keep a set……
AbbVie Inc. (ABBV) Presents at EU Clinical Trial Regulation: Latest Developments and Upcoming Opportunities Transcript
AbbVie Inc. (ABBV) EU Clinical Trial Regulation: Latest Developments and Upcoming Opportunities May 28, 2026 10:00 AM EDTCompany ParticipantsSonia...…
Colorectal Cancer Alliance and GCAR Announce Collaboration to Advance a Groundbreaking Adaptive Clinical Trial Platform for Colorectal Cancer: KLEOS - Morningstar
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Single infusion of controversial drug changed severe depression symptoms within hours, study finds
Researchers say a single intravenous ketamine infusion can rapidly relieve severe depression and suicidal thoughts when traditional antidepressants fail.…
GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment Transcript
GSK plc (GSK) Discusses Bepirovirsen Phase III Data and Advances in Hepatitis B Treatment May 28, 2026 10:00 AM EDTCompany ParticipantsConstantin Fest -...…
WHO urges Ebola treatments, vaccines be tested only in trials amid Bundibugyo outbreak
May 28 - The World Health Organization said on Thursday that experimental treatments and vaccines for Ebola caused by the Bundibugyo virus should only be used in clinical trials, a…
Closely watched Parkinson's drug from Biogen, Denali comes up short
High-level results have led the companies to scrap a mid-stage trial, though Denali plans to continue independently running a separate experiment focused on a certain subset of Par…
Hansa Biopharma AB (publ) (HNSBF) Discusses Top Line Results from PAES Study on Imlifidase in Highly Sensitized Kidney Transplant Patients Transcript
Hansa Biopharma AB (publ) (HNSBF) Discusses Top Line Results from PAES Study on Imlifidase in Highly Sensitized Kidney Transplant Patients May 27, 2026 8:00...…
Precision BioSciences, Inc. (DTIL) Discusses Updates on PBG and HBV Program and ELIMINATE-B Trial Results - Slideshow
2026-05-27. The following slide deck was published by Precision BioSciences, Inc.…
Adjuvant Radiation Boosts High-Risk Bladder Cancer Control
For patients with high-risk muscle-invasive bladder cancer, adjuvant radiotherapy improves disease control without increasing the risk of serious side effects.…
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at ASCO Transcript
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at ASCO May 26, 2026 8:00 AM...…
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at ASCO - Slideshow
2026-05-26. The following slide deck was published by Corbus Pharmaceuticals Holdings, Inc.…
NeuroScientific hails 80% clinical response in Crohn’s stem cell program
NeuroScientific Biopharmaceuticals has reported an 80% response rate from five Crohn’s disease patients treated with its StemSmart cell therapy, with all patients showing improveme…
Moxifloxacin Outperforms Azithromycin in M genitalium Cure
A 10-day course of moxifloxacin 400 mg once daily demonstrates superior efficacy to a 6-day course of azithromycin 500 mg once daily for treating Mycoplasma genitalium infection.…
How to Build a Clinical Trial Search App in 5 Minutes - Clinical Trials API Tutorial
What We're Building In the next 5 minutes, you'll build a simple web app that lets users...…
This Pill Can Prevent You From Getting Covid-19 After Exposure to the Disease-Causing Virus, According to a Clinical Trial
The drug showed promising results in an international study involving nearly 2,400 participants, and the U.S. Food and Drug Administration is expected to make an approval decision …
EMA OKs New Option for Pulmonary Fibrosis
The oral therapy is intended for adults with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis, two fibrotic lung diseases with limited treatment options.…
Bicara Therapeutics Inc. (BCAX) Discusses New Clinical Data on Investigational Therapy for HPV Negative Head and Neck Cancer at ASCO Transcript
Bicara Therapeutics Inc. (BCAX) Discusses New Clinical Data on Investigational Therapy for HPV Negative Head and Neck Cancer at ASCO May 22, 2026 8:30 AM...…
First Real-World Study Supports Sotatercept for PAH
Researchers share their experience with sotatercept in 91 patients with pulmonary arterial hypertension, the first report on outcomes outside clinical studies.…
STAT+: Closely watched experimental Parkinson’s drug fails key clinical trial
Biogen and Denali Therapeutics said a closely watched experimental therapy for Parkinson’s disease failed to slow the degenerative brain disorder in a randomized trial.…
GLP-1 drugs may reduce the risk of cancer progressing, study suggests
Research from the Cleveland Clinic found that people who started a GLP-1 drug after their diagnosis was less likely to progress to stage 4.…
New Eli Lilly weight loss drug has dramatic effects in clinical trial
An experimental anti-obesity injection helped patients reach new levels of weight loss previously only achievable through bariatric surgery, according to new data from the pharmace…
People lost up to 85 pounds on Lilly’s experimental weight loss drug, company says
The results — the most weight loss ever seen in a medication trial — put the drug’s effectiveness on par with bariatric surgery.…
Lawmakers, health leaders make bipartisan push to expand clinical trials access
Protara Therapeutics, Inc. (TARA) Discusses Interim Safety and Durability Data From STARBORN-1 Trial of TARA-002 in Lymphatic Malformations - Slideshow
2026-05-20. The following slide deck was published by Protara Therapeutics, Inc.…
New treatment offers hope for endometrial cancer patients
The TroFuse-005 trial involved 776 patients with endometrial cancer whose disease worsened after receiving both platinum chemotherapy and immunotherapy.…
Relay Therapeutics, Inc. (RLAY) Discusses Initial Clinical Data for Zovegalisib in Vascular Anomalies - Slideshow
2026-05-20. The following slide deck was published by Relay Therapeutics, Inc.…
Watch live: Reimagining Clinical Trials – Expanding Access by Meeting Patients Where They Are
Gelteq begins clinical trial for veterinary antiparasitic drug
New drug approach offers hope for patients with recurrent aggressive cancers
Merck announces that sac-TMT, a new cancer drug, demonstrated strong results in phase 3 trials for advanced or recurrent endometrial cancer patients.…
NRx Pharmaceuticals: 'Sell' On ZYESAMI/NRX-101 Failures & Depression Market Uncertainty
NRx Pharmaceuticals (NRXP) is downgraded from 'Buy' to 'Sell' following failures in ZYESAMI and NRX-101 clinical trials.…
Revolutionary Cancer Tx Could Transform Autoimmune Disease
Researchers are testing CAR T-cell therapy as a way to reset the immune system in lupus, Graves’ disease and other conditions where the body’s defenses go rogue.…
Relay Therapeutics, Inc. (RLAY) Discusses Initial Clinical Data for Zovegalisib in Vascular Anomalies Transcript
Relay Therapeutics, Inc. (RLAY) Discusses Initial Clinical Data for Zovegalisib in Vascular Anomalies May 19, 2026 8:00 AM EDTCompany ParticipantsPeter...…
Protara Therapeutics, Inc. (TARA) Discusses Interim Safety and Durability Data From STARBORN-1 Trial of TARA-002 in Lymphatic Malformations Transcript
Protara Therapeutics, Inc. (TARA) Discusses Interim Safety and Durability Data From STARBORN-1 Trial of TARA-002 in Lymphatic Malformations May 19, 2026...…
Design Therapeutics, Inc. (DSGN) Discusses Data from RESTORE-FA Trial of DT-216P2 for Friedreich Ataxia - Slideshow
2026-05-19. The following slide deck was published by Design Therapeutics, Inc.…
Ipsen S.A. (IPSEY) Discusses Phase II LANTIC Data and Innovation in Engineered Neuroinhibitors for Aesthetic Indications Transcript
Ipsen S.A. (IPSEY) Discusses Phase II LANTIC Data and Innovation in Engineered Neuroinhibitors for Aesthetic Indications May 18, 2026 9:00 AM EDTCompany...…
Design Therapeutics, Inc. (DSGN) Discusses Data from RESTORE-FA Trial of DT-216P2 for Friedreich Ataxia Transcript
Design Therapeutics, Inc. (DSGN) Discusses Data from RESTORE-FA Trial of DT-216P2 for Friedreich Ataxia May 18, 2026 8:00 AM EDTCompany ParticipantsSean...…
Mixed Topline Results for Anti-Tau Agent in Phase 2 Trial
Although a new phase 2 study missed its primary endpoint, the anti-tau therapy diranersen reduces tau pathology and shows signs of slowing clinical decline in early AD.…
New pancreatic cancer pill could reshape treatment as early trial results stun researchers
A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 patients with RAS mutations.…
Tango Therapeutics: 'Hold' On Combination Strategy Shift Of Vopimetostat
Tango Therapeutics shifts strategy to vopimetostat combinations, backed by a cash runway into 2028. Find out why TNGX stock is downgraded to a hold.…
Fecal transplants for autism deliver success in clinical trials
Scientific research continues to uncover interesting connections between the gut microbiome and human health, including everything from depression to PTSD to autoimmune disease. An…
Upadacitinib After TNF Inhibitor Failure Improves RA Control
In patients with active RA, switching to upadacitinib after failure of a single TNF inhibitor is more effective in reducing disease activity at 12 weeks than using a second TNF inh…
Massive Bio and OpenAI Collaborate to Expand Clinical Trial Access Through AI Pre-Screening - HLTH
Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.…
Sunnybrook Health Sciences Centre receives $41-million to bolster Canada’s position for clinical trials
Contribution to Toronto organization from Weston family will benefit whole country, CEO says…
Pancreatic cancer patient Ben Sasse sees 'massive' tumor reduction with experimental new drug
Former Sen. Ben Sasse of Nebraska reveals an experimental cancer drug helped shrink his tumors by 76% after a stage 4 metastatic pancreatic cancer diagnosis.…